Genticel
Genticel develops therapeutic solutions for women already infected by HPV before high grade lesions or cervical cancer occur.
- Stage Concept Only
- Industry Biotechnology
- Location Labège, Midi-Pyrénées, France
- Currency EUR
- Employees 30
- Website genticel.com
Team
-
Benedikt TimmermanFounder, Chief Executive OfficerPhD University of Ghent, Belgium & MBA, INSEAD.
20 years international career in Life Science Companies
Previously Sr Director R&D of Novartis Seeds (1994 – 2000), member of EU Executive Committee (1995 – 2000) & member of Novartis Agribusiness (now Syngenta) global corporate Licensing and Acquisitions team (1997 – 2000) -
Martin KochChief Financial Officer
Engineer, INAPG, France & MBA, INSEAD.
20 years of international career in financial and operational management
Previously, Sales Director Oncology Cephalon Pharma France (2006 – 2007) and Controlling and Finance Director functions at Elan & Zeneus Pharma UK (2001 – 2005) -
Marie-Christine BisseryChief Scientific Officer
PhD and Pharm. D Paris & Washington University;
Academia: 7 years , Washington University, Michigan Cancer Foundation, Wayne State University Medical School
Previously, International Director of Oncology (2007– 2008) and Deputy Head of Oncology (2005-2007), Sanofi-aventis; Sr Director Experimental Therapeutics and Translational Research, Aventis Pharma (2000-2004)
Previous Investors
-
Idinvests Partners, Edmond de Rothschild Investment Partners,Unconfirmed
InnoBio fund, The FSI and CDC Entreprises,Unconfirmed
Amundi Private Equity Funds (Amundi PEF), IRDIUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.